Healthcare

Techseriesinsight > Blog > News > Healthcare

Illustration of stent inside coronary artery

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

XyloCor Doses First Patient in Transformative Gene Therapy Trial

XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 trial, designed to...

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

Sinovac’s New Board Holds First Meeting, Elects Andrew Y. Yan as Chairman

Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon...

July 9, 2025
PRNewswire
Healthcare, News

Smile Train Launches Africa’s Largest Cleft Center in Ghana

Smile Train, the world’s largest cleft-focused organization, opened a state-of-the-art Cleft Leadership Center (CLC) at the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana on June 25, 2025. The “National Cleft Care...

July 8, 2025
Business Wire
Biotechnology, Healthcare, News

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of stock options to purchase 45,000 shares...

TDWI-Insight-Accelerator-Adopting-Modern-AI-Powered-Cloud-Data-Management

July 8, 2025
Business Wire
Data Management Platform, Healthcare, News

Senior Market Sales® (SMS) Acquires MIC Insurance Services

MIC Insurance Services, a highly successful New Jersey health insurance agency, has entered into a strategic partnership with Senior Market Sales (SMS), one of the industry’s premier insurance marketing organizations (IMOs)....

July 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and...

July 1, 2025
Business Wire
Data Management Platform, Healthcare, News

Tenovi: All Health Data Stays in the U.S.

In response to new federal rules issued by the U.S. Department of Justice restricting the transfer of personal health data to foreign adversaries, Tenovi reaffirms its long-standing commitment to domestic data...

July 1, 2025
Business Wire
Healthcare, News

DocGo to Provide Medical Transportation Services to Albany Stratton VA Medical Center

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its Ambulnz subsidiary was awarded a multi-year...

July 1, 2025
Business Wire
Biotechnology, Healthcare, News

Vertex’s ALYFTREK® Approved by European Commission

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have...

July 1, 2025
Business Wire
Artificial Intelligence, Biotechnology, Healthcare, News

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter...